{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:11:24Z","timestamp":1783440684479,"version":"3.54.6"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP15km0908001"],"award-info":[{"award-number":["JP15km0908001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health, Labor, and Welfare"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI"],"award-info":[{"award-number":["KAKENHI"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012331","name":"LEO foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Keio Gijuku Academic Development Funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Autoimmune diseases are devastating conditions in which the immune system is directed against the host, leading to life-threatening destruction of organs. Although autoantigens are ill-defined in most autoimmune diseases, this is not the case in the skin. Autoimmune bullous diseases have been extensively studied with detailed characterization of autoantigens, the epitopes that are targeted, and the mechanisms of action that mediate autoimmune tissue destruction. Pemphigus is an autoimmune bullous disease caused by circulating IgG that targets two desmosomal proteins, desmoglein 1 and 3, which are crucial for cell\u2013cell adhesion of keratinocytes. Binding of auto-antibodies to desmogleins impairs keratinocyte adhesion, leading to severe blistering disease. Mouse models that recapitulate the human disease have been instrumental in elucidating the detailed pathophysiology. Taking advantage of the fact that desmogleins are specifically targeted in pemphigus, studying humoral and cellular autoimmunity against these autoantigens provides us with an opportunity to understand not only the effector mechanisms of B and T cells in mediating pathology but also how autoreactive lymphocytes are regulated during development in the thymus and post-development in the periphery. This review introduces pemphigus and its subtypes as prototypic autoimmune diseases from which recent basic and translational developments should provide insight into how autoimmunity develops.<\/jats:p>","DOI":"10.1093\/intimm\/dxz030","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T15:17:46Z","timestamp":1552922266000},"page":"431-437","source":"Crossref","is-referenced-by-count":13,"title":["Autoimmunity and immunological tolerance in autoimmune bullous diseases"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-8821","authenticated-orcid":false,"given":"Hayato","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Iriki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Kamata","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"2022071820583807400_CIT0001","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2022071820583807400_CIT0002","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"2022071820583807400_CIT0003","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"2022071820583807400_CIT0004","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"2022071820583807400_CIT0005","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.160.5.1509","article-title":"Human autoantibodies against a desmosomal core protein in pemphigus foliaceus","volume":"160","author":"Koulu","year":"1984","journal-title":"J. Exp. Med."},{"key":"2022071820583807400_CIT0006","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"2022071820583807400_CIT0007","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1126\/science.1071559","article-title":"C-cadherin ectodomain structure and implications for cell adhesion mechanisms","volume":"296","author":"Boggon","year":"2002","journal-title":"Science"},{"key":"2022071820583807400_CIT0008","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/jid.2011.448","article-title":"Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules","volume":"132","author":"Ohyama","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583807400_CIT0009","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0010","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2022071820583807400_CIT0011","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.0901691","article-title":"Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus","volume":"183","author":"Yamagami","year":"2009","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0012","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.jid.5701132","article-title":"Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies","volume":"128","author":"Ishii","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583807400_CIT0013","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1038\/ncomms5167","article-title":"Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients","volume":"5","author":"Cho","year":"2014","journal-title":"Nat. Commun."},{"key":"2022071820583807400_CIT0014","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2011.449","article-title":"Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display","volume":"132","author":"Saleh","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583807400_CIT0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4049\/jimmunol.1600567","article-title":"Determinants of VH1-46 cross-reactivity to pemphigus vulgaris autoantigen desmoglein 3 and rotavirus antigen VP6","volume":"197","author":"Cho","year":"2016","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0016","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.1200842","article-title":"Cutting edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen","volume":"189","author":"Qian","year":"2012","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0017","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/sj.jid.5700341","article-title":"Production of low titers of anti-desmoglein 1 IgG autoantibodies in some patients with staphylococcal scalded skin syndrome","volume":"126","author":"Anzai","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583807400_CIT0018","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022071820583807400_CIT0019","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022071820583807400_CIT0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-0039.1994.tb02390.x","article-title":"HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method","volume":"44","author":"Niizeki","year":"1994","journal-title":"Tissue Antigens"},{"key":"2022071820583807400_CIT0021","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1523-1747.ep12337585","article-title":"HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese","volume":"109","author":"Miyagawa","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583807400_CIT0022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"2022071820583807400_CIT0023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00915155","article-title":"Subclass distribution of human IgG autoantibodies in pemphigus","volume":"8","author":"Jones","year":"1988","journal-title":"J. Clin. Immunol."},{"key":"2022071820583807400_CIT0024","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1346-8138.1990.tb03008.x","article-title":"Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus","volume":"17","author":"Shirakata","year":"1990","journal-title":"J. Dermatol."},{"key":"2022071820583807400_CIT0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2230.1993.tb02175.x","article-title":"IgG subclasses in pemphigus in Indian and UK populations","volume":"18","author":"Wilson","year":"1993","journal-title":"Clin. Exp. Dermatol."},{"key":"2022071820583807400_CIT0026","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2022071820583807400_CIT0027","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1172\/JCI44425","article-title":"Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity","volume":"120","author":"Yamagami","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2022071820583807400_CIT0028","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.170.1.635","article-title":"Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles","volume":"170","author":"Veldman","year":"2003","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0029","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.181.2.1526","article-title":"Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris","volume":"181","author":"Takahashi","year":"2008","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0030","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0031","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI8748","article-title":"Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus","volume":"105","author":"Amagai","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2022071820583807400_CIT0032","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/1521-4141(200203)32:3<627::AID-IMMU627>3.0.CO;2-1","article-title":"Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris","volume":"32","author":"Tsunoda","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"2022071820583807400_CIT0033","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/intimm\/dxh150","article-title":"Auto-reactive B cells against peripheral antigen, desmoglein 3, escape from tolerance mechanism","volume":"16","author":"Ota","year":"2004","journal-title":"Int. Immunol."},{"key":"2022071820583807400_CIT0034","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ajpath.2011.04.015","article-title":"Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris","volume":"179","author":"Tsunoda","year":"2011","journal-title":"Am. J. Pathol."},{"key":"2022071820583807400_CIT0035","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/dxn095","article-title":"Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance","volume":"20","author":"Ota","year":"2008","journal-title":"Int. Immunol."},{"key":"2022071820583807400_CIT0036","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxr020","article-title":"Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris","volume":"23","author":"Yokoyama","year":"2011","journal-title":"Int. Immunol."},{"key":"2022071820583807400_CIT0037","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1172\/JCI57379","article-title":"Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice","volume":"121","author":"Takahashi","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2022071820583807400_CIT0038","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.4049\/jimmunol.1300348","article-title":"Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation","volume":"191","author":"Nishimoto","year":"2013","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0039","first-page":"77","article-title":"Paraneoplastic pemphigus","volume":"12","author":"Anhalt","year":"1997","journal-title":"Adv. Dermatol."},{"key":"2022071820583807400_CIT0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"2022071820583807400_CIT0041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaad.2006.06.007","article-title":"Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies","volume":"56","author":"Cummins","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"2022071820583807400_CIT0042","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0190-9622(99)70111-8","article-title":"Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans","volume":"41","author":"Chorzelski","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"2022071820583807400_CIT0043","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2133.1999.02669.x","article-title":"Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour","volume":"140","author":"Wolff","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"2022071820583807400_CIT0044","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"2022071820583807400_CIT0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1378\/chest.117.2.603","article-title":"Paraneoplastic pemphigus associated with bronchiolitis obliterans","volume":"117","author":"Takahashi","year":"2000","journal-title":"Chest"},{"key":"2022071820583807400_CIT0046","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1378\/chest.112.6.1704","article-title":"Necrotizing tracheobronchitis with progressive airflow obstruction associated with paraneoplastic pemphigus","volume":"112","author":"Osmanski","year":"1997","journal-title":"Chest"},{"key":"2022071820583807400_CIT0047","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM200307243490421","article-title":"CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman\u2019s disease","volume":"349","author":"Hoffman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2022071820583807400_CIT0048","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.1203536","article-title":"Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus","volume":"191","author":"Hata","year":"2013","journal-title":"J. Immunol."},{"key":"2022071820583807400_CIT0049","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2017.07.010","article-title":"The mechanisms of T cell selection in the thymus","volume":"38","author":"Takaba","year":"2017","journal-title":"Trends Immunol."},{"key":"2022071820583807400_CIT0050","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"2022071820583807400_CIT0051","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cell.2015.10.013","article-title":"Fezf2 orchestrates a thymic program of self-antigen expression for immune tolerance","volume":"163","author":"Takaba","year":"2015","journal-title":"Cell"},{"key":"2022071820583807400_CIT0052","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/jid.2010.330","article-title":"Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance","volume":"131","author":"Wada","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"2022071820583807400_CIT0053","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"2022071820583807400_CIT0054","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"2022071820583807400_CIT0055","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210433","article-title":"Not paraneoplastic pemphigus but pemphigus vulgaris in a patient with thymoma","author":"Saraya","year":"2015","journal-title":"BMJ Case Rep."},{"key":"2022071820583807400_CIT0056","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1097\/JTO.0b013e3181f1f63f","article-title":"The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond","volume":"5","author":"Marx","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"2022071820583807400_CIT0057","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10875-015-0176-y","article-title":"Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy","volume":"35","author":"Kisand","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"2022071820583807400_CIT0058","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CCO.0000000000000290","article-title":"Dermatologic complications of anti-PD-1\/PD-L1 immune checkpoint antibodies","volume":"28","author":"Sibaud","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"2022071820583807400_CIT0059","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jdcr.2016.05.009","article-title":"Development of bullous pemphigoid during nivolumab therapy","volume":"2","author":"Damsky","year":"2016","journal-title":"JAAD Case Rep."},{"key":"2022071820583807400_CIT0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/2326-6066.CIR-15-0123","article-title":"Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1","volume":"4","author":"Naidoo","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"2022071820583807400_CIT0061","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni0901-816","article-title":"Regulatory T cells in the control of immune pathology","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat. Immunol."},{"key":"2022071820583807400_CIT0062","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"2022071820583807400_CIT0063","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2022071820583807400_CIT0064","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2022071820583807400_CIT0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"2022071820583807400_CIT0066","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/302761","article-title":"X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3","volume":"66","author":"Bennett","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"2022071820583807400_CIT0067","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat. Genet."},{"key":"2022071820583807400_CIT0068","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","article-title":"Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity","volume":"122","author":"Gambineri","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583807400_CIT0069","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clim.2011.06.006","article-title":"Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"141","author":"Otsubo","year":"2011","journal-title":"Clin. Immunol."},{"key":"2022071820583807400_CIT0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"39","author":"Wildin","year":"2002","journal-title":"J. Med. Genet."},{"key":"2022071820583807400_CIT0071","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1210\/jc.2003-031080","article-title":"Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome","volume":"88","author":"Owen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2022071820583807400_CIT0072","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/MOG.0b013e32830c9022","article-title":"Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome","volume":"24","author":"Ruemmele","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"key":"2022071820583807400_CIT0073","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.140.4.466","article-title":"Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"140","author":"Nieves","year":"2004","journal-title":"Arch. Dermatol."},{"key":"2022071820583807400_CIT0074","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cgh.2005.12.014","article-title":"Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome","volume":"4","author":"De Benedetti","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2022071820583807400_CIT0075","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJM200106073442304","article-title":"Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation","volume":"344","author":"Baud","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2022071820583807400_CIT0076","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2005.08.047","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature","volume":"55","author":"McGinness","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"2022071820583807400_CIT0077","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-015-0538-0","article-title":"Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease","volume":"17","author":"Hadaschik","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"2022071820583807400_CIT0078","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583807400_CIT0079","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"2022071820583807400_CIT0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ebiom.2017.12.022","article-title":"Langerhans cells prevent autoimmunity via expansion of keratinocyte antigen-specific regulatory T cells","volume":"27","author":"Kitashima","year":"2018","journal-title":"EBioMedicine"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/advance-article-pdf\/doi\/10.1093\/intimm\/dxz030\/28498019\/dxz030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/31\/7\/431\/45022531\/intimm_31_7_431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/31\/7\/431\/45022531\/intimm_31_7_431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T20:59:50Z","timestamp":1658177990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article\/31\/7\/431\/5385508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":80,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,19]]},"published-print":{"date-parts":[[2019,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxz030","relation":{},"ISSN":["1460-2377"],"issn-type":[{"value":"1460-2377","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,3,19]]}}}